ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2022

Targeting chronic COVID-19 lung injury; Tofacitinib can be used against tissue-resident memory T cells.

Sepideh Zununi Vahed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.